Pulmonx (NASDAQ:LUNG – Get Rating) and Axonics (NASDAQ:AXNX – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Profitability This table compares Pulmonx and Axonics’ net margins, return on equity […]
Axonics (NASDAQ:AXNX – Get Rating) and Pulmonx (NASDAQ:LUNG – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership. Profitability This table compares Axonics and Pulmonx’s net margins, return on equity […]
IRVINE, Calif. (AP) Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a loss of $15.2 million in its fourth quarter. On a per-share basis, the Irvine, California-based company said it had a loss of 34 cents.
The Sacral Nerve Stimulation Market is driven by increasing cases of overactive bladder, urinary retention, and fecal incontinence. In addition, the growing adoption of minimally invasive therapies